Transverse Medical Closes Financing and Restructures Board of Directors

April 15, 2024—Transverse Medical, Inc. recently announced the closing of a Series B1 financing and the subsequent restructuring of its Board of Directors. These developments prepare the company for future financing and its clinical study strategy for the next-generation Point-Guard cerebral protection system for use in transcatheter aortic valve replacement procedures.

According to Transverse Medical, David C. Blowers has been appointed to the Board of Directors and will serve as the Corporate Secretary of the company, Carl St. Bernard has been reinstated as an independent member to the Board of Directors, and Eric Goslau will remain as President & CEO and a member of the Board.

Additionally, Rahul P. Sharma, MBBS, has joined the Board of Directors as an independent member and will also Chair the Medical Advisory Board.

The company stated that Mr. Blowers, a wealth management and finance professional, is Vice Chairman of Northern Trust. Mr. Blowers holds an MBA with a concentration in Finance from the Kellogg School of Northwestern University in Chicago, Illinois.

Mr. St. Bernard first joined the company in March of 2021 and has served as an Executive Advisor and Board Director. He is currently the President & Chief Executive Officer of Alta Biomaterials. Previously, he was President and Chief Executive Officer of Tryton Medical and has over 30 years of experience in the life sciences field and medical device markets.

Dr. Sharma is the Director of Structural Interventions at Stanford Healthcare, Associate Director of the Cardiac Catheterization Laboratory and Clinical Associate Professor of Medicine at Stanford University in Stanford, California. He has clinical expertise in structural heart and cerebral embolic protection.

Additionally, Dr. Sharma is cofounder and board member of Synchron, Inc. the endovascular brain-computer interface company. He serves as Chief Medical Officer of Egnite, a company developing artificial intelligence for cardiovascular medicine.